Liquidia Corporation (LQDA)
NASDAQ: LQDA · Real-Time Price · USD
66.91
-1.26 (-1.85%)
Sep 1, 2026, 4:00 PM EDT - Market closed
Liquidia Employees
Liquidia had 216 employees as of December 31, 2025. The number of employees increased by 46 or 27.06% compared to the previous year.
Employees
216
Change (1Y)
46
Growth (1Y)
27.06%
Revenue / Employee
$2,087,532
Profits / Employee
$641,694
Market Cap
5.99B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 216 | 46 | 27.06% |
| Dec 31, 2024 | 170 | 25 | 17.24% |
| Dec 31, 2023 | 145 | 82 | 130.16% |
| Dec 31, 2022 | 63 | 11 | 21.15% |
| Dec 31, 2021 | 52 | 1 | 1.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Dr. Reddy's Laboratories | 27,527 |
| Elanco Animal Health | 9,900 |
| Amneal Pharmaceuticals | 8,700 |
| Hims & Hers Health | 2,442 |
| Alkermes | 2,050 |
| Lantheus Holdings | 1,193 |
| Indivior Pharmaceuticals | 838 |
| Supernus Pharmaceuticals | 778 |
LQDA News
- 21 hours ago - Liquidia Corporation to Participate in Wells Fargo Annual Healthcare Conference - GlobeNewsWire
- 15 days ago - Liquidia reports Q2 EPS 74c, consensus 84c - TheFly
- 16 days ago - Liquidia downgraded to Market Perform from Outperform at LifeSci Capital - TheFly
- 16 days ago - Liquidia price target raised to $108 from $62 at Wells Fargo - TheFly
- 16 days ago - Liquidia price target raised to $92 from $79 at BofA - TheFly
- 16 days ago - Liquidia price target raised to $106 from $68 at Raymond James - TheFly
- 20 days ago - Liquidia Earnings Call Transcript: Q2 2026 - Transcripts
- 20 days ago - Liquidia Earnings release: Q2 2026 - Filings